Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging.
about
Advancements in MR imaging of the prostate: from diagnosis to interventionsThe role of magnetic resonance imaging in the diagnosis and management of prostate cancerMultiparametric magnetic resonance imaging of the prostate: current conceptsTargeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancerApplications of magnetic resonance spectroscopy in radiotherapy treatment planning.Prostate MRI and 3D MR spectroscopy: how we do itValue of 11C-choline PET and PET/CT in patients with suspected prostate cancer.Peripheral zone prostate cancer. Pre-treatment evaluation with MR and 3D ¹H MR spectroscopic imaging: correlation with pathologic findings.Diffusion-weighted MRI and its role in prostate cancer.Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancerFive-point Likert scaling on MRI predicts clinically significant prostate carcinomaValue of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancerValue of T1/T2-weighted magnetic resonance imaging registration to reduce the postbiopsy hemorrhage effect for prostate cancer localizationNonvisible tumors on multiparametric magnetic resonance imaging does not predict low-risk prostate cancer.New imaging techniques in prostate cancer.Imaging techniques for prostate cancer: implications for focal therapyImaging localized prostate cancer: current approaches and new developments.Evolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate.Multiparametric magnetic resonance imaging of prostate cancer.Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging.Current role and future perspectives of magnetic resonance spectroscopy in radiation oncology for prostate cancer.New horizons in prostate cancer imaging.MR imaging of the prostate in clinical practice.Advances in MR spectroscopy of the prostate.Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer.Multidisciplinary functional MR imaging for prostate cancer.Modalities for imaging of prostate cancer.Imaging in prostate cancer.Role of MRI in prostate cancer detection.Mapping of prostate cancer by 1H MRSI.Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies.Interpretation and reporting multiparametric prostate MRI: a primer for residents and novices.The optimal timing of post-prostate biopsy magnetic resonance imaging to guide nerve-sparing surgery.Effect of Prostate Biopsy Hemorrhage on MRDW and MRS Imaging.Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine.Implementation of Multi-parametric Prostate MRI in Clinical Practice.Navigating MRI-TRUS fusion biopsy: optimizing the process and avoiding technical pitfalls.Multiparametric MRI of the prostate gland: technical aspects.DCE MRI of prostate cancer.Could Magnetic Resonance Imaging Help to Identify the Presence of Prostate Cancer Before Initial Biopsy? The Development of Nomogram Predicting the Outcomes of Prostate Biopsy in the Chinese Population.
P2860
Q24594047-4297847B-1CE9-446E-8289-62C13226489FQ26849794-7DCE0179-D9D4-42B3-A833-15C2E677093CQ26859699-C11C77F6-7852-49B1-B967-385F43DF19C8Q27027567-B4182A60-71BC-4CC0-B0FF-D65D4C5D3CBEQ31061313-90E9D32E-574D-4982-86D6-24CCFD4EE12EQ33954515-9B5A21E2-D22E-4766-A0D1-F00A2BA27B01Q34570356-94FFC834-D9FC-4B46-811B-24FC1BBCD66DQ34611905-F810CF97-5059-4824-8768-E45B8AB2FD4AQ34742733-FAA35F00-463F-4129-8385-0D1AEF8CB54CQ35722781-C595F0D8-6623-40D5-8526-9F9D97D2C998Q35763119-55CDAF9C-84A6-4E83-9E53-304F73661BD6Q35985579-91E14F4A-A54C-4FF1-A433-0E519F1451AFQ36106249-A8047EAC-DD0B-4FAD-9686-18C0CAB3A3E8Q36387925-28C05E39-74E1-4733-9F5A-785E662807E7Q36456144-8FDC5B53-C1FF-4A54-A819-1F203A40CFB2Q36460818-99C0492C-73A5-4C2E-8070-D8C07FDF7076Q36469177-35FDFFF6-B3C1-4D29-BA73-F3BA4E0EF02DQ36605752-FA90E674-8FC1-40E2-901C-81CCDB949228Q36761055-BFE8F558-AF10-4461-8729-A8A66FD1AE23Q36809840-7F812AD6-E4E5-45BA-98EA-4CD305046266Q36866123-B638579D-87DC-4448-9F93-A5B9FCDEE437Q37242030-4D920389-EF2A-49F6-9A5D-D5EC28670B50Q37270567-7D169544-87F6-4F60-B0EF-A09FF05C0D09Q37300338-E63FC84D-6E5E-4730-99E4-FD1C416DE04CQ37401554-1952B33F-F5E0-4CA1-BF9D-C88CF3D79DA3Q37406508-EA8E7842-53B0-47E8-8185-B29EDBEBDEA8Q37719273-1AF18C76-0309-4151-8631-8EC36D422563Q37875083-EC5CB55F-6B11-4DF1-A275-FBCD58C690A5Q38089710-D28AA058-13D5-4E5F-ACEA-7528C39FB715Q38114017-ABF71532-C921-4E78-935A-932943565A66Q38178850-CCDEEFC3-7208-45E8-B575-3E3CA59AFC76Q38190885-346AAA50-4B29-4D37-85ED-C8603B904F99Q38283233-86F1DA76-7028-4A2A-8B5E-071CA5EF054DQ38468586-DABB1716-8B39-4197-8E0F-B531CBB30138Q38479113-A0D5B385-69C0-40BF-AE21-B64FE6A0E108Q38528397-D174CCB0-1E7E-46F8-9662-5C007AC52338Q38664945-B87E827C-0F88-4995-8EFE-FCDB9F3C49FEQ38830576-094131D4-869F-4E09-8BF5-458E66E661AFQ38837802-A6B026DE-1918-4547-A07B-7C00D888605DQ39554008-F06BE39C-0CFC-4599-ADE5-F672F7539C95
P2860
Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Organ-confined prostate cancer ...... and MR spectroscopic imaging.
@en
Organ-confined prostate cancer ...... and MR spectroscopic imaging.
@nl
type
label
Organ-confined prostate cancer ...... and MR spectroscopic imaging.
@en
Organ-confined prostate cancer ...... and MR spectroscopic imaging.
@nl
prefLabel
Organ-confined prostate cancer ...... and MR spectroscopic imaging.
@en
Organ-confined prostate cancer ...... and MR spectroscopic imaging.
@nl
P2093
P1476
Organ-confined prostate cancer ...... and MR spectroscopic imaging.
@en
P2093
Aliya Qayyum
Benjamin M Yeh
Fergus V Coakley
Jeffrey D Olpin
John Kurhanewicz
Peter R Carroll
P304
P356
10.2214/AJR.183.4.1831079
P407
P577
2004-10-01T00:00:00Z